CN114642642A — 5-(2-氟苯基)-n-甲基-1-(3-吡啶基磺酰基)-1h-吡咯-3-甲胺制剂
Assigned to Shanghai Tin Tsz Bio Valley Biological Engineering Co ltd · Expires 2022-06-21 · 4y expired
What this patent protects
本发明提供了一种5‑(2‑氟苯基)‑N‑甲基‑1‑(3‑吡啶基磺酰基)‑1H‑吡咯‑3‑甲胺制剂。具体地,所述制剂为水溶液或为由所述水溶液冻干得到的冻干制剂,其中,所述水溶液包括0.1‑20mg/ml的5‑(2‑氟苯基)‑N‑甲基‑1‑(3‑吡啶基磺酰基)‑1H‑吡咯‑3‑甲胺‑L‑焦谷氨酸盐;且所述水溶液pH为2‑5。本发明的制剂具有高存储稳定性。
USPTO Abstract
本发明提供了一种5‑(2‑氟苯基)‑N‑甲基‑1‑(3‑吡啶基磺酰基)‑1H‑吡咯‑3‑甲胺制剂。具体地,所述制剂为水溶液或为由所述水溶液冻干得到的冻干制剂,其中,所述水溶液包括0.1‑20mg/ml的5‑(2‑氟苯基)‑N‑甲基‑1‑(3‑吡啶基磺酰基)‑1H‑吡咯‑3‑甲胺‑L‑焦谷氨酸盐;且所述水溶液pH为2‑5。本发明的制剂具有高存储稳定性。
Drugs covered by this patent
- Cubicin (Daptomycin) · Baxter
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.